Physician profile
Andrew P Hurvitz
NPI 1083842371
$2,559.85
in general payments reported to CMS, 2019-2025
8 companies · $38.97 in 2025
The $38.97 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,261 · 2023: $733 · 2024: $527 · 2025: $38.97.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,299.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Impactortho, INC. | $1,200.00 | 2022 | |
| Arthrex, INC. | $586.87 | 2023 | |
| Elevate Surgical Co | $217.76 | 2022-2025 | |
| Lima USA, INC. | $146.43 | 2023 | Lantern Surgical Assistant |
| Stryker Corporation | $142.09 | 2024 | Inspace, Tornier Perform Reversed Augmented Glenoid, Salvation |
| Smith+Nephew, INC. | $135.08 | 2024 | Bone Anchors With Arthroscopic Delivery System |
| Depuy Synthes Sales INC. | $74.88 | 2024 | Healix Knotless Peek, Milagro, Rigidloop |
| Illuminoss Medical, INC. | $56.74 | 2024-2025 | Photodynamic Bone Stabilization Procedure Pack |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Hurvitz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.